Cargando…
A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study
OBJECTIVES: This study was conducted to evaluate the effect of low-dose chlormadinone acetate, an antiandrogen agent, on the persistence rate of active surveillance in patients with low-risk prostate cancer. METHODS: The study was a multicenter, placebo-controlled, double-blind, randomized controlle...
Autores principales: | Sugimoto, Mikio, Kakehi, Yoshiyuki, Horie, Shigeo, Hirao, Yoshihiko, Akaza, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825478/ https://www.ncbi.nlm.nih.gov/pubmed/34698353 http://dx.doi.org/10.1093/jjco/hyab162 |
Ejemplares similares
-
The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study
por: Fujimoto, Kiyohide, et al.
Publicado: (2013) -
Ethinylestradiol/Chlormadinone Acetate: Dermatological Benefits
por: Guerra-Tapia, Aurora, et al.
Publicado: (2012) -
The impact of baseline [−2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort
por: Hirama, Hiromi, et al.
Publicado: (2013) -
Low quality of life in men with chronic prostatitis-like symptoms
por: Sugimoto, Mikio, et al.
Publicado: (2022) -
Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
por: Vázquez, Mercedes Gómez, et al.
Publicado: (2012)